1. Hong, G-S, Heun, R, Jessen, F, Maier, W, Kölsch, H. 2007. Gene variations in GSTM3 are a risk factor for Alzheimer's disease. In Neurobiology of aging, 30, 691-6. doi:. https://pubmed.ncbi.nlm.nih.gov/17904251/
2. Yu, Ke-Da, Fan, Lei, Di, Gen-Hong, Shen, Zhen-Zhou, Shao, Zhi-Ming. 2009. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. In Breast cancer research and treatment, 121, 485-96. doi:10.1007/s10549-009-0585-9. https://pubmed.ncbi.nlm.nih.gov/19856098/
3. Chen, Tao, Jinlin, Duan, Wang, Fan, Liu, Yanfeng, Zhang, Yonglong. 2022. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling. In Cancer letters, 538, 215692. doi:10.1016/j.canlet.2022.215692. https://pubmed.ncbi.nlm.nih.gov/35487311/
4. Loktionov, A, Watson, M A, Gunter, M, Speakman, C T, Bingham, S A. . Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. In Carcinogenesis, 22, 1053-60. doi:. https://pubmed.ncbi.nlm.nih.gov/11408349/
5. Yang, Fu, Wen, Jing, Luo, Kongjia, Fu, Jianhua. 2021. Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma. In Diagnostic pathology, 16, 10. doi:10.1186/s13000-021-01069-4. https://pubmed.ncbi.nlm.nih.gov/33482859/
6. Tan, X, Wang, Y, Han, Y, Thompson, T C, Cao, G. 2013. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression. In British journal of cancer, 109, 3105-15. doi:10.1038/bjc.2013.669. https://pubmed.ncbi.nlm.nih.gov/24157827/
7. Li, Bo, Zhou, Jing, Zhang, Guowei, Chen, Jia, Guan, Huaijin. . Relationship Between the Altered Expression and Epigenetics of GSTM3 and Age-Related Cataract. In Investigative ophthalmology & visual science, 57, 4721-32. doi:10.1167/iovs.16-19242. https://pubmed.ncbi.nlm.nih.gov/27607418/
智鼠故事 
